Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-995
Closed -$259K 385
2025
Q3
$259K Buy
+995
New +$262K ﹤0.01% 389
2025
Q2
Sell
-5,600
Closed -$1.48M 335
2025
Q1
$1.48M Buy
+5,600
New +$1.51M 0.04% 201
2023
Q4
Sell
-698
Closed -$340K 282
2023
Q3
$340K Buy
+698
New +$328K 0.02% 246
2023
Q2
Sell
-717
Closed -$348K 410
2023
Q1
$348K Sell
717
-2,839
-80% -$1.4M 0.02% 262
2022
Q4
$1.82M Buy
3,556
+3,049
+601% +$1.6M 0.11% 78
2022
Q3
$246K Sell
507
-4,013
-89% -$1.95M 0.02% 270
2022
Q2
$2.12M Buy
4,520
+1,015
+29% +$452K 0.11% 77
2022
Q1
$1.52M Buy
3,505
+3,080
+725% +$1.29M 0.07% 131
2021
Q4
$197K Buy
+425
New +$188K 0.01% 303

Other funds holding HUM

AIA Group's HUM Position: Q4 2025 in Review

AIA Group sold out of Humana (HUM) in Q4 2025, closing a stake of 995 shares — an estimated $259K sold.

AIA Group first reported a position in HUM in Q4 2021 and held it in 9 quarters. The position peaked at $2.12M in Q2 2022. 863 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • AIA Group reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • AIA Group sold 995 Humana shares in Q4 2025, an estimated $259K.
  • AIA Group first reported a position in Humana in Q4 2021 and held it in 9 quarters.
  • AIA Group's Humana position peaked at $2.12M in Q2 2022.
  • 863 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on AIA Group's 13F filing for Q4 2025, filed 9 Feb 2026.